The effect of serum soluble Fas and soluble Fas ligandin patients with hepatitis B. [J]. Journal of Chongqing Medical University (4):365-367(2000) DOI: 10.13406/j.cnki.cyxb.2000.04.012.
The effect of serum soluble Fas and soluble Fas ligandin patients with hepatitis B
To evaluate the effect of soluble Fas antigen (sFas) and soluble Fas ligand (sFasL) in the pathogenesis of hepatitis B. Methods Serum sFas and sFasL were detected by ELISA in 39 patients with hepatitis B. 8 healthy persons served as normal control. These levels were compared with the index of disease activity
including ALT levels
STB and PT levels. Results Serum sFas levels in moderate and severe degree CHB patients (CAH
5.38±3.50ng/ml) were significantly higher than those in other groups(P<0.01)
and serum sFasL levels in hepatic failure patients (FH
2.76±0.49ng/ml) were notably higher than those in other groups(P<0.01). Serum sFas and sFasL levels were correlated with disease activity
and most cases of the former had favourable prognosis. Conclusion The soluble form of Fas antigen in serum seemed to inhibit Fas-mediated apoptosis
and serum sFasL may reflect the severity of liver inflammation. They play important roles in hepatic apoptosis and necrosis
and may be responsible symbols for diagnosing pathogenetic condition and prognosis in hepatitis B.
The effect of soybean isoflavones on induction of apoptosis on gastric cancer cell SGC-7901
Preliminary experimental study of the effects of vitreous cryopreservation with tetramethylpyrazine on schwann’s cell apoptosis and the expression of regulating gens
Related Author
ZHANG Junwen
et al
汤为学
LIU Jian-wen
et al
陈增刚
袁新
欧云生
Related Institution
Department of Gastroenterology, College of Clinical Medicine, Chongqing Medical University
重庆医科大学基础医学院病理生理教研室
Department of Orthopedics,the First Affiliated Hospital,Chongqing Medical University